This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-22 May 2026, and includes updates on hantavirus, chikungunya, Ebola disease outbreak, avian influenza, measles, and an overview of respiratory virus epidemiology in the EU/EEA.
Respiratory virus activity remains low overall across the EU/EEA: RSV: activity has returned to baseline inter-seasonal levels. Influenza: activity remains at baseline inter-seasonal levels. SARS-CoV-2: activity remains at very low levels overall.
This handbook provides an updated overview of commonly used laboratory protocols for the characterisation of SARS-CoV-2, provided by the AURORAE consortium.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 May 2026, and includes updates on hantavirus, mpox, Middle East respiratory syndrome coronavirus (MERS-CoV), Salmonella Stanley, and an overview of respiratory virus epidemiology in the EU/EEA.
Most respiratory virus activity remains low overall across the EU/EEA. RSV: low activity; still the main contributor to severe disease, with the seasonal peak largely passed. Influenza: activity has returned to inter-seasonal levels. SARS-CoV-2: Very low activity overall, despite early signs of sustained transmission in primary care.
Most respiratory virus activity remains low overall across the EU/EEA. RSV: low activity and returning to baseline levels, with the seasonal peak already passed in most countries. Influenza: activity has returned to inter-seasonal levels. COVID 19: Very low activity.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 25-30 April 2026, and includes updates on influenza, cholera, chikungunya virus disease, and an overview of respiratory virus epidemiology in the EU/EEA.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-24 April 2026, and includes updates on avian influenza, Salmonella Bovismorbificans, and an overview of respiratory virus epidemiology in the EU/EEA.
Most respiratory virus activity remains low overall across the EU/EEA. RSV: moderate activity but decreasing, with the seasonal peak already passed in most countries. Influenza: activity has returned to inter-seasonal levels. COVID 19: Very low activity.